| __timestamp | Ligand Pharmaceuticals Incorporated | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 396000000 |
| Thursday, January 1, 2015 | 13380000 | 364000000 |
| Friday, January 1, 2016 | 21221000 | 376000000 |
| Sunday, January 1, 2017 | 26887000 | 382000000 |
| Monday, January 1, 2018 | 27863000 | 432000000 |
| Tuesday, January 1, 2019 | 55908000 | 457000000 |
| Wednesday, January 1, 2020 | 59392000 | 463000000 |
| Friday, January 1, 2021 | 69012000 | 508000000 |
| Saturday, January 1, 2022 | 36082000 | 539000000 |
| Sunday, January 1, 2023 | 24537000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Zoetis Inc. and Ligand Pharmaceuticals Incorporated have taken distinct paths in their R&D investments. From 2014 to 2023, Zoetis consistently outspent Ligand, with its R&D expenses growing from $396 million to a staggering $614 million, marking a 55% increase. In contrast, Ligand's R&D spending peaked in 2021 at $69 million, before declining to $24 million in 2023, a 65% drop. This divergence highlights Zoetis's commitment to innovation, while Ligand appears to be recalibrating its strategy. As the pharmaceutical landscape evolves, these spending patterns may offer insights into each company's future trajectory and market positioning. Stay tuned as we continue to track these industry giants and their investment in innovation.
Sanofi or Zoetis Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Zoetis Inc. vs argenx SE
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Bio-Techne Corporation
Research and Development Expenses Breakdown: Zoetis Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Zoetis Inc. vs PTC Therapeutics, Inc.
GSK plc vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated
Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending